Management of massive haemorrhage in transfusion medicine services in the Middle East and North Africa.
massive transfusion
plasma
platelets
red blood cells
trauma
Journal
Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606
Informations de publication
Date de publication:
20 Jun 2024
20 Jun 2024
Historique:
revised:
03
06
2024
received:
24
03
2024
accepted:
05
06
2024
medline:
20
7
2024
pubmed:
20
7
2024
entrez:
20
7
2024
Statut:
aheadofprint
Résumé
Massive transfusion protocols (MTPs) are critical in managing haemorrhage, yet their utilization varies. There is lack of data on the utilization of MTPs in the Middle East and North Africa (MENA) region. This study aims to assess the degree of utilization of MTPs in the region. We conducted a survey to collect data on MTP use, inviting medical directors of transfusion services from various hospitals. Data were analysed to determine the prevalence of MTP utilization, their compositions, challenges in application and areas of future need. Eighteen respondents participated, representing 11 countries in the region. Thirteen hospitals implemented MTP, and eight included paediatrics. Eleven institutions used more than one definition of massive haemorrhage, with the most common being ≥10 red blood cell (RBC) units transfused for adults and replacement of >50% total blood volume in paediatrics. The majority of sites with MTPs utilized 1:1:1 RBCs:platelets:plasma ratio (70%). Variations were observed in the types and blood groups of components used. Two sites utilized whole blood, while six are considering it for future use. Utilization of adjunctive agents and frequency of laboratory testing varied among the sites. Challenges included the lack of medical expertise in protocol development, adherence and paediatric application. The need assessment emphasized the need for developing regional guidelines, standardized protocols and training initiatives. Although several hospitals have adopted MTPs, variations exist in activation criteria, blood product ratios and monitoring. Challenges include the lack of medical expertise, protocol adherence and addressing paediatric needs. Standardizing protocols, enhancing training and paediatric application are crucial for improving massive transfusion management in the region.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Massive transfusion protocols (MTPs) are critical in managing haemorrhage, yet their utilization varies. There is lack of data on the utilization of MTPs in the Middle East and North Africa (MENA) region. This study aims to assess the degree of utilization of MTPs in the region.
MATERIALS AND METHODS
METHODS
We conducted a survey to collect data on MTP use, inviting medical directors of transfusion services from various hospitals. Data were analysed to determine the prevalence of MTP utilization, their compositions, challenges in application and areas of future need.
RESULTS
RESULTS
Eighteen respondents participated, representing 11 countries in the region. Thirteen hospitals implemented MTP, and eight included paediatrics. Eleven institutions used more than one definition of massive haemorrhage, with the most common being ≥10 red blood cell (RBC) units transfused for adults and replacement of >50% total blood volume in paediatrics. The majority of sites with MTPs utilized 1:1:1 RBCs:platelets:plasma ratio (70%). Variations were observed in the types and blood groups of components used. Two sites utilized whole blood, while six are considering it for future use. Utilization of adjunctive agents and frequency of laboratory testing varied among the sites. Challenges included the lack of medical expertise in protocol development, adherence and paediatric application. The need assessment emphasized the need for developing regional guidelines, standardized protocols and training initiatives.
CONCLUSION
CONCLUSIONS
Although several hospitals have adopted MTPs, variations exist in activation criteria, blood product ratios and monitoring. Challenges include the lack of medical expertise, protocol adherence and addressing paediatric needs. Standardizing protocols, enhancing training and paediatric application are crucial for improving massive transfusion management in the region.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 International Society of Blood Transfusion.
Références
Simmons JW, Powell MF. Acute traumatic coagulopathy: pathophysiology and resuscitation. Br J Anaesth. 2016;117:iii31–iii43.
Thorn S, Güting H, Maegele M, Gruen RL, Mitra B. Early identification of acute traumatic coagulopathy using clinical prediction tools: a systematic review. Medicina (Kaunas). 2019;55:653.
Consunji R, Elseed A, El‐Menyar A, Sathian B, Rizoli S, Al‐Thani H, et al. The effect of massive transfusion protocol implementation on the survival of trauma patients: a systematic review and meta‐analysis. Blood Transfus. 2020;18:434–445.
McDaniel LM, Etchill EW, Raval JS, Neal MD. State of the art: massive transfusion. Transfus Med. 2014;24:138–144.
Lin VS, Sun E, Yau S, Abeyakoon C, Seamer G, Bhopal S, et al. Definitions of massive transfusion in adults with critical bleeding: a systematic review. Crit Care. 2023;27:265.
Treml AB, Gorlin JB, Dutton RP, Scavone BM. Massive transfusion protocols: a survey of academic medical centers in the United States. Anesth Analg. 2017;124:277–281.
Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471–482.
Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma. 2011;71:S318–S328.
Horst J, Leonard JC, Vogel A, Jacobs R, Spinella PC. A survey of US and Canadian hospitals' paediatric massive transfusion protocol policies. Transfus Med. 2016;26:49–56.
Thomasson RR, Yazer MH, Gorham JD, Dunbar NM. International assessment of massive transfusion protocol contents and indications for activation. Transfusion. 2019;59:1637–1643.
Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447–458.
Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, et al. International forum on the management of major haemorrhage: summary. Vox Sang. 2022;117:746–753.
Moore SA, Raval JS. Massive transfusion: a review. Ann Blood. 2022;7:18.
Hanna K, Bible L, Chehab M, Asmar S, Douglas M, Ditillo M, et al. Nationwide analysis of whole blood hemostatic resuscitation in civilian trauma. J Trauma Acute Care Surg. 2020;89:329–335.
James SL, Lucchesi LR, Bisignano C, Castle CD, Dingels ZV, Fox JT, et al. Morbidity and mortality from road injuries: results from the Global Burden of Disease Study 2017. Inj Prev. 2020;26:i46–i56.
Schuster KM, Davis KA, Lui FY, Maerz LL, Kaplan LJ. The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion? Transfusion. 2010;50:1545–1551.
Etchill E, Sperry J, Zuckerbraun B, Alarcon L, Brown J, Schuster K, et al. The confusion continues: results from an American Association for the Surgery of Trauma survey on massive transfusion practices among United States trauma centers. Transfusion. 2016;56:2478–2486.
Evangelista ME, Gaffley M, Neff LP. Massive transfusion protocols for pediatric patients: current perspectives. J Blood Med. 2020;11:163–172.
Sinha R, Roxby D. Change in transfusion practice in massively bleeding patients. Transfus Apher Sci. 2011;45:171–174.
Shih AW, Al Khan S, Wang AY, Dawe P, Young PY, Greene A, et al. Systematic reviews of scores and predictors to trigger activation of massive transfusion protocols. J Trauma Acute Care Surg. 2019;87:717–729.
D'Souza K, Norman M, Greene A, Finney CJF, Yan MTS, Trudeau JD, et al. Prediction of massive transfusion with the Revised Assessment of Bleeding and Transfusion (RABT) score at Canadian level I trauma centers. Injury. 2023;54:19–24.
Yang JC, Wang QS, Dang QL, Sun Y, Xu CX, Jin ZK, et al. Investigation of the status quo of massive blood transfusion in China and a synopsis of the proposed guidelines for massive blood transfusion. Medicine (Baltimore). 2017;96:e7690.
Sanderson BJ, Field JD, Estcourt LJ, Wood EM, Coiera EW. Massive transfusion experience, current practice and decision support: a survey of Australian and New Zealand anaesthetists. Anaesth Intensive Care. 2021;49:214–221.
Waters JH, Bonnet MP. When and how should I transfuse during obstetric hemorrhage? Int J Obstet Anesth. 2021;46:102973.
Broxton S, Medeiros R, Abuzeid A, Peterson C, Schumacher A. Implementation of a massive transfusion protocol: evaluation of its use and efficacy. J Trauma Nurs. 2018;25:92–97.
Sanderson B, Coiera E, Asrianti L, Field J, Estcourt LJ, Wood EM. How well does your massive transfusion protocol perform? A scoping review of quality indicators. Blood Transfus. 2020;18:423–433.
Carlsen MIS, Brede JR, Medby C, Uleberg O. Transfusion practice in Central Norway – a regional cohort study in patients suffering from major haemorrhage. BMC Emerg Med. 2024;24:3.
Simmons K, Piotrowski M, Kweeder S, Lightcap A, Brown L. Implementation of a multimodal interdisciplinary massive transfusion protocol educational bundle improves knowledge and self‐efficacy. J Perianesth Nurs. 2023;38:398–403.